Zevra Therapeutics, Inc. (ZVRA)
9.51
+0.48
(+5.32%)
USD |
NASDAQ |
Jan 22, 11:10
Zevra Therapeutics Free Cash Flow: -24.23M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| XOMA Royalty Corp. | -15.89M |
| Verastem, Inc. | -140.93M |
| ADMA Biologics, Inc. | 40.61M |
| Akebia Therapeutics, Inc. | 32.17M |
| NovaBay Pharmaceuticals, Inc. | -7.012M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 4.709M |
| Cash from Investing (Quarterly) | -4.576M |
| Cash from Financing (Quarterly) | 6.53M |
| Free Cash Flow Per Share (Quarterly) | 0.0743 |
| Free Cash Flow to Equity (Quarterly) | 3.714M |
| Free Cash Flow to Firm (Quarterly) | 5.297M |
| Free Cash Flow Yield | -4.66% |